Literature DB >> 12502709

A synthetic peptide ligand of neural cell adhesion molecule (NCAM), C3d, promotes neuritogenesis and synaptogenesis and modulates presynaptic function in primary cultures of rat hippocampal neurons.

Darya Kiryushko1, Thomas Kofoed, Galina Skladchikova, Arne Holm, Vladimir Berezin, Elisabeth Bock.   

Abstract

The neural cell adhesion molecule (NCAM) plays a key role in morphogenesis of the nervous system and in remodeling of neuronal connections accompanying regenerative and cognitive processes. Recently, a new synthetic ligand of NCAM, the C3-peptide, which binds to the NCAM IgI module, has been identified by means of combinatorial chemistry (Rønn, L. C. B, Olsen, M., Ostergaard, S., Kiselyov, V., Berezin, V., Mortensen, M. T., Lerche, M. H., Jensen, P. H., Soroka, V., Saffell, J. L., Doherty, P., Poulsen, F. M., Bock, E., Holm, A., and Saffells, J. L. (1999) Nat. Biotechnol. 17, 1000-1005). In vitro, the dendrimeric form of C3, termed C3d, disrupts NCAM-mediated cell adhesion, induces neurite outgrowth, and triggers intracellular signaling cascades similar to those activated by homophilic NCAM binding. The peptide may therefore be expected to regulate regeneration and synaptic plasticity. Here we demonstrate that in primary cultures of hippocampal neurons: 1) C3d induces a sustained neuritogenic response, the neuritogenic activity of the compound being dependent on the dose, starting time, and duration of peptide application; 2) the peptide triggers the neuritogenic response by forming an adhesive substratum necessary for NCAM-mediated neurite formation and elongation; 3) C3d promotes synapse formation; and 4) C3d modulates the presynaptic function, causing a transient increase of the function at low (2 and 5 microm) doses and a reduction when applied at a higher concentration (10 microm). The effect of the peptide is dependent on the activation of the fibroblast growth factor receptor. We suggest that C3d may constitute a useful lead for the development of compounds for treatment of various neurodegenerative disorders.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12502709     DOI: 10.1074/jbc.M211628200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

Review 1.  NCAM function in the adult brain: lessons from mimetic peptides and therapeutic potential.

Authors:  Glenn Dallérac; Claire Rampon; Valérie Doyère
Journal:  Neurochem Res       Date:  2013-03-14       Impact factor: 3.996

2.  Role of a neural cell adhesion molecule found in cerebrospinal fluid as a potential biomarker for epilepsy.

Authors:  Wei Wang; Liang Wang; Jing Luo; Zhiqin Xi; Xuefeng Wang; Guojun Chen; Lan Chu
Journal:  Neurochem Res       Date:  2012-01-05       Impact factor: 3.996

3.  Tolerability, safety and pharmacokinetics of the FGLL peptide, a novel mimetic of neural cell adhesion molecule, following intranasal administration in healthy volunteers.

Authors:  Ravi Anand; Michael Seiberling; Thierry Kamtchoua; Rolf Pokorny
Journal:  Clin Pharmacokinet       Date:  2007       Impact factor: 6.447

4.  Increased cell-cell adhesion, a novel effect of R-(-)-deprenyl.

Authors:  V Jenei; K Zor; K Magyar; J Jakus
Journal:  J Neural Transm (Vienna)       Date:  2005-03-23       Impact factor: 3.575

5.  Post-training intrahippocampal injection of synthetic poly-alpha-2,8-sialic acid-neural cell adhesion molecule mimetic peptide improves spatial long-term performance in mice.

Authors:  Cédrick Florian; Jane Foltz; Jean-Chrétien Norreel; Geneviève Rougon; Pascal Roullet
Journal:  Learn Mem       Date:  2006-05-16       Impact factor: 2.460

6.  A peptide motif from the second fibronectin module of the neural cell adhesion molecule, NCAM, NLIKQDDGGSPIRHY, is a binding site for the FGF receptor.

Authors:  Jacob Jacobsen; Vladislav Kiselyov; Elisabeth Bock; Vladimir Berezin
Journal:  Neurochem Res       Date:  2008-03-27       Impact factor: 3.996

Review 7.  NCAM Mimetic Peptides: Potential Therapeutic Target for Neurological Disorders.

Authors:  Chengyan Chu; Yue Gao; Xiaoyan Lan; Aline Thomas; Shen Li
Journal:  Neurochem Res       Date:  2018-07-12       Impact factor: 3.996

8.  Role of glial cell line-derived neurotrophic factor (GDNF)-neural cell adhesion molecule (NCAM) interactions in induction of neurite outgrowth and identification of a binding site for NCAM in the heel region of GDNF.

Authors:  Janne Nielsen; Kamil Gotfryd; Shizhong Li; Nikolaj Kulahin; Vladislav Soroka; Kim K Rasmussen; Elisabeth Bock; Vladimir Berezin
Journal:  J Neurosci       Date:  2009-09-09       Impact factor: 6.167

9.  Specific detection of CD56 (NCAM) isoforms for the identification of aggressive malignant neoplasms with progressive development.

Authors:  Stefan Gattenlöhner; Thorsten Stühmer; Ellen Leich; Matthias Reinhard; Benjamin Etschmann; Hans-Ulrich Völker; Andreas Rosenwald; Edgar Serfling; Ralf Christian Bargou; Georg Ertl; Hermann Einsele; Hans-Konrad Müller-Hermelink
Journal:  Am J Pathol       Date:  2009-02-26       Impact factor: 4.307

Review 10.  NCAM mimetic peptides: Pharmacological and therapeutic potential.

Authors:  Vladimir Berezin; Elisabeth Bock
Journal:  J Mol Neurosci       Date:  2004       Impact factor: 2.866

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.